Market Cap
5432308224.00
Grifols, S.A.
Exchange: nyse
GRFS is the ticker symbol for Grifols S.A., a global healthcare company listed on the New York Stock Exchange (NYSE). Grifols specializes in the development, manufacture, and distribution of plasma-derived medicines and hospital solutions. The company operates across three main business segments: Bioscience, which focuses on the production of plasma protein therapies; Diagnostic, which provides diagnostic tools and services; and Hospital, which supplies intravenous solutions and nutrition therapies. With a strong presence in over 30 countries, Grifols continues to be a significant player in the biopharmaceutical industry, contributing to advancements in patient care through its innovative products and services.
0.139175589476
0.179705350682
-30.11%
3.75